<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03446755</url>
  </required_header>
  <id_info>
    <org_study_id>B670201733915</org_study_id>
    <nct_id>NCT03446755</nct_id>
  </id_info>
  <brief_title>Use of an Intra Uterine Balloon to Prevent Recurrent Adhesions (REpAIR)</brief_title>
  <official_title>The Use of an Intrauterine Balloon in Preventing Adhesion Recurrence After Hysteroscopic Adhesiolysis: a Feasibility Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients suffering of subfertility as a consequence of intrauterine adhesions could be&#xD;
      treated with hysteroscopic adhesiolysis. Adhesion recurrence may occur postoperative. An&#xD;
      intrauterine balloon, inserted after hysteroscopic adhesiolysis, may prevent adhesion&#xD;
      reformation.&#xD;
&#xD;
      A Foley catheter can serve for this purpose, but its not ideal. COOK medicalÂ® developed a&#xD;
      hearth shaped intrauterine balloon to reduce bleeding after intrauterine surgery.&#xD;
&#xD;
      We aimed to perform a pilot study of 10 procedures with insertion of a hearth shaped&#xD;
      intrauterine balloon as antiadhesion method subsequent to a hysteroscopic adhesiolysis, to&#xD;
      study its feasibility in terms of surgeon's and patient's experience.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 17, 2018</start_date>
  <completion_date type="Actual">December 16, 2020</completion_date>
  <primary_completion_date type="Actual">December 16, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>To evaluate the feasibility of a hearth shaped intrauterine balloon as antiadhesion method subsequent to a hysteroscopic adhesiolysis in terms of surgeon's and patient's experience.</intervention_model_description>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of recurrent adhesions after adhesiolysis</measure>
    <time_frame>5-10 weeks after adhesiolysis</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The number of complications after adhesiolysis</measure>
    <time_frame>5-10 weeks after adhesiolysis</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain after placement of the intra uterine balloon</measure>
    <time_frame>1 to 6 days after adhesiolysis</time_frame>
    <description>via Visual Analogue Scale (VAS scale). The patient has to indicate her pain score from 0 (no pain) to 10 (worst pain ever).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications after placement of the intra uterine balloon</measure>
    <time_frame>1 to 6 days after adhesiolysis</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain at the time of the removal of the intra uterine balloon</measure>
    <time_frame>6 days after adhesiolysis</time_frame>
    <description>via Visual Analogue Scale (VAS scale). The patient has to indicate her pain score from 0 (no pain) to 10 (worst pain ever).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction after removal of the intra uterine balloon</measure>
    <time_frame>6 days after adhesiolysis</time_frame>
    <description>Via questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Malaise after placement of the intra uterine balloon</measure>
    <time_frame>6 days after adhesiolysis</time_frame>
    <description>Via questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily functioning after placement of the intra uterine balloon (absence from work, impact on work productivity, impact on household, physical activity, daily life)</measure>
    <time_frame>6 days after adhesiolysis</time_frame>
    <description>Via questionnaire and via via Visual Analogue Scale (VAS scale). The patient has to indicate her daily functioning from 0 (the balloon had no influence on my daily function) to 10 (because of the balloon I couldn't do anything of my daily work).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The ease of inserting the intra uterine balloon</measure>
    <time_frame>once at the time of the surgical procedure (adhesiolysis). This is day 0 of the study</time_frame>
    <description>Via questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The ease of removing the intra uterine balloon</measure>
    <time_frame>6 days after adhesiolysis</time_frame>
    <description>Via questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Adhesion; Uterus, Internal</condition>
  <arm_group>
    <arm_group_label>Intrauterine balloon (Cook medical)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Insertion of a hearth shaped intrauterine balloon immediately after hysteroscopic adhesiolysis and left in place for 7 days under antibiotic prophylaxis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>intra uterine Cook balloon</intervention_name>
    <description>Insertion of a hearth shaped intrauterine balloon immediately after hysteroscopic adhesiolysis and left in place for 7 days under antibiotic prophylaxis.</description>
    <arm_group_label>Intrauterine balloon (Cook medical)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with intra uterine adhesions scheduled for hysteroscopic adhesiolysis&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Only female patients will be included</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <state>East-Flanders</state>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 24, 2018</study_first_submitted>
  <study_first_submitted_qc>February 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2018</study_first_posted>
  <last_update_submitted>July 1, 2021</last_update_submitted>
  <last_update_submitted_qc>July 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>antiadhesion treatment</keyword>
  <keyword>Asherman's syndrome</keyword>
  <keyword>hysteroscopic adhesiolysis</keyword>
  <keyword>intrauterine adhesions</keyword>
  <keyword>intrauterine balloon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tissue Adhesions</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

